BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3031380)

  • 1. Effect of clomipramine treatment on dog platelet alpha 2-adrenergic receptivity.
    Villeneuve A; Berlan M; Paris H; Tran MA; Lafontan M; Montastruc JL; Montastruc P
    J Pharmacol; 1986; 17(4):644-50. PubMed ID: 3031380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients.
    Mores N; Martire M; Pistritto G; Volpe AR; Menini E; Folli G; Cardillo C
    J Hypertens; 1994 Aug; 12(8):939-45. PubMed ID: 7814853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal and fetal platelet responses and adrenoceptor binding characteristics.
    Jones CR; McCabe R; Hamilton CA; Reid JL
    Thromb Haemost; 1985 Feb; 53(1):95-8. PubMed ID: 2986310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine.
    Corby DG; O'Barr TP
    Dev Pharmacol Ther; 1981; 2(4):215-25. PubMed ID: 6266790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation.
    Wallace MA; Agarwal KC; Garcia-Sainz JA; Fain JN
    J Cell Biochem; 1982; 18(2):213-20. PubMed ID: 6121823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
    Macfarlane DE; Stump DC
    Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interactions between alpha 1, alpha 2 and beta receptors in the blood pressure effects of adrenaline and noradrenaline in the dog].
    Mouillé P; Dabiré H; Joly G; Schmitt H
    J Pharmacol; 1983; 14(3):325-32. PubMed ID: 6138461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
    McKernan RM; Howard MJ; Motulsky HJ; Insel PA
    Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
    J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ageing and the alpha 2-adrenergic system of the platelet.
    Davis PB; Silski C
    Clin Sci (Lond); 1987 Nov; 73(5):507-13. PubMed ID: 2824117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down regulation of alpha 2 adrenergic receptor numbers in platelets by insulin.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1992 Apr; 1134(3):292-6. PubMed ID: 1313699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
    Brodde OE; Daul A; O'Hara N; Bock KD
    J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of dog platelet alpha-adrenergic receptor: lack of in vivo down regulation by adrenergic agonist treatments.
    Villeneuve A; Berlan M; Lafontan M; Montastruc JL
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 81(1):181-7. PubMed ID: 2861047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between amitraz and alpha 2-adrenoceptors inhibits epinephrine-induced canine platelet aggregation.
    Koeiman NR; Hsu WH
    Arch Int Pharmacodyn Ther; 1991; 310():56-65. PubMed ID: 1663333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dog.
    Estan L; Senard JM; Tran MA; Montastruc JL; Berlan M
    Br J Pharmacol; 1990 Oct; 101(2):329-36. PubMed ID: 2175232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
    Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
    Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and reversible desensitisation of vascular and platelet alpha 2 adrenoceptors.
    Hamilton CA; Deighton NM; Reid JL
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):534-40. PubMed ID: 2886922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of imidazoline agents on the aggregation of human platelets.
    Pinthong D; Songsermsakul P; Rattanachamnong P; Kendall DA
    J Pharm Pharmacol; 2004 Feb; 56(2):213-20. PubMed ID: 15005880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.